🇺🇸 FDA

Drug profile · INN

neostigmine methylsulfate

NEOSTIGMINE METHYLSULFATE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

neostigmine methylsulfate (NEOSTIGMINE METHYLSULFATE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN neostigmine methylsulfate
Brand NEOSTIGMINE METHYLSULFATE
Route INJECTION
Formulation INJECTABLE
Originator Regeneron Ireland Designated Activity Company (DAC)

Frequently asked questions

What is neostigmine methylsulfate?

neostigmine methylsulfate (NEOSTIGMINE METHYLSULFATE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for neostigmine methylsulfate?

NEOSTIGMINE METHYLSULFATE is a marketed brand name for neostigmine methylsulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of neostigmine methylsulfate?

neostigmine methylsulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.